CNBC Pro Talks: Asset manager Patrick Armstrong on Significant Tech, sector outlook and shares to small

CNBC Pro Talks: Asset manager Patrick Armstrong on Significant Tech, sector outlook and shares to small


As traders continue on to navigate a slew of market place risks, join CNBC’s next Pro Talks for insights on how to occur out on leading.

CNBC’s Joumanna Bercetche will inquire Patrick Armstrong, chief financial commitment officer at Plurimi Wealth, for his sights on in which markets are likely up coming, defensive vs. growth methods, which stocks to acquire – and what to quick.

Armstrong manages resources which include the Plurimi AI Global Equity Method. The fund, which defeat the MSCI Globe index to rise 8.2% in Oct, counts Apple, Google-guardian Alphabet, semiconductor big ASML and oil key Shell amongst its greatest holdings.

He’ll share his massive winners and losers of the year so far, and why he relies on AI to assistance with stock choice.

Have issues you would like us to include in the discussion? Submit them listed here.

Watch the Pro Talks on Wednesday, Nov. 23 at 8 p.m. Singapore time/12 p.m. London time/7 a.m. ET.



Supply

Investors are misreading news about the Iran war, analysts say as markets whipsaw
World

Investors are misreading news about the Iran war, analysts say as markets whipsaw

An Iranian flag flutters as a woman walks past damaged buildings amid a 10-day ceasefire between Lebanon and Israel, in the southern suburbs of Beirut, Lebanon, April 20, 2026. Marko Djurica | Reuters “Complacent” investors risk getting wrong-footed as they continue to misread developments in the Iran war, analysts said after markets reacted to the […]

Read More
Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to  billion
World

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday. Lilly will pay $3.25 billion upfront, and the remaining payments are contingent upon clinical, […]

Read More
USA Rare Earth to buy Brazil’s Serra Verde for .8 billion to build supply outside Asia
World

USA Rare Earth to buy Brazil’s Serra Verde for $2.8 billion to build supply outside Asia

USA Rare Earth has announced plans to buy Brazilian rare earths miner Serra Verde in a deal worth $2.8 billion in cash and shares, as it seeks to challenge China’s dominance of the supply chain. The Oklahoma-headquartered company said it will pay $300 million in cash and $126.9 million in its own newly issued stock […]

Read More